Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
7,282,619
-
Share change
-
+817,197
-
Total reported value
-
$7,797,682
-
Price per share
-
$1.07
-
Number of holders
-
47
-
Value change
-
+$687,878
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q3 2025
As of 30 Sep 2025,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,282,619 shares.
The largest 10 holders included
Tejara Capital Ltd, AdvisorShares Investments LLC, BANK OF AMERICA CORP /DE/, MARSHALL WACE, LLP, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, MMCAP International Inc. SPC, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, and Virtu Financial LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.